major histocompatibility complex, class II, DR18 | |
| Haplotypes groups | DRA*01:DRB1*0302 DRA*01:DRB5*0303 |
| Structure (See HLA-DR) | |
| Identifiers | alpha *0101 |
| Symbol(s) | HLA-DRA |
| EBI-HLA | DRA*0101 |
| Identifiers | beta 1 *0302 *0303 |
| Symbol(s) | HLA-DRB1 |
| EBI-HLA | DRB5*0302 |
| EBI-HLA | DRB1*0303 |
| Shared data | |
| Locus | chr.6 6p21.31 |
HLA-DR18 (DR18) is a HLA-DR serotype that recognizes the DRB1*0302 and *0303 gene products. Compared to DR17 which is found at high frequency in Western Europe, DR18 is found more in SE Europe and Central Asia.
| DRB1* | DR18 | DR3 | DR17 | Sample |
| allele | % | % | % | size (N) |
| 0302 | 66 | 24 | 3 | 317 |
| 0303 | 60 | 40 | 5 | |
DR18 recognizes the DRB1*0302 and *0303, the thoroughness of recognition is fair, but better than DR3.
DR18 seropositivity is associated with rheumatoid polyarthritis[2]
DRB1*0302 is positively associated with juvenile diabetes,[3] nuclear helicase Mi-2 autoantibodies in inflammatory inclusion body myositis.[4]
DR18 Haplotypes | |||
| Serotypes | DRA | DRB1 | DRB3 |
|---|---|---|---|
| DR18(3)-DR52 |
|
|
|
| DQA1 | DQB1 | DRB1 | |
| D18(3)-DQ2(2.5) |
|
|
|
| HLA-A | HLA -B | DRB1 | |
| A33-B58-DR18(3) |
|
|
|
HLA-DR18 is genetically linked to DR52 and HLA-DQ2 serotypes. These serotypesare the result of gene products from the HLA-DRB3* and HLA DQA1*0501 and HLA DQB1*0201 alleles.